Pushpakumar Sathnur, Kundu Sourav, Sen Utpal
Department of Physiology & Biophysics, University of Louisville School of Medicine, 500 South Preston Street, A-1115; Louisville, KY-40292, USA.
Curr Med Chem. 2014;21(32):3662-72. doi: 10.2174/0929867321666140706142335.
High level of homocysteine (hyperhomocysteinemia, HHcy) is associated with increased risk for vascular disease. Evidence for this emerges from epidemiological studies which show that HHcy is associated with premature peripheral, coronary artery and cerebrovascular disease independent of other risk factors. Possible mechanisms by which homocysteine causes vascular injury include endothelial injury, DNA dysfunction, proliferation of smooth muscle cells, increased oxidative stress, reduced activity of glutathione peroxidase and promoting inflammation. HHcy has been shown to cause direct damage to endothelial cells both in vitro and in vivo. Clinically, this manifests as impaired flow-mediated vasodilation and is mainly due to a reduction in nitric oxide synthesis and bioavailability. The effect of impaired nitric oxide release can in turn trigger and potentiate atherothrombogenesis and oxidative stress. Endothelial damage is a crucial aspect of atherosclerosis and precedes overt manifestation of disease. In addition, endothelial dysfunction is also associated with hypertension, diabetes, ischemia reperfusion injury and neurodegenerative diseases. Homocysteine is a precursor of hydrogen sulfide (H2S) which is formed by transulfuration process catalyzed by the enzymes, cystathionine β-synthase and cystathionine γ-lyase. H2S is a gasotransmitter that has emerged recently as a novel mediator in cardiovascular homeostasis. As a potent vasodilator, it plays several roles which include regulation of vessel diameter, protection of endothelium from redox stress, ischemia reperfusion injury and chronic inflammation. However, the precise mechanism by which it mediates these beneficial effects is complex and still remains unclear. Current evidence indicates H2S modulates cellular functions by a variety of intracellular signaling processes. In this review, we summarize the mechanisms of HHcy-induced endothelial dysfunction and the metabolism and physiological functions of H2S as a protective agent.
高同型半胱氨酸水平(高同型半胱氨酸血症,HHcy)与血管疾病风险增加相关。这一观点源于流行病学研究,这些研究表明,HHcy与外周血管疾病、冠状动脉疾病和脑血管疾病的过早发生相关,且独立于其他风险因素。同型半胱氨酸导致血管损伤的可能机制包括内皮损伤、DNA功能障碍、平滑肌细胞增殖、氧化应激增加、谷胱甘肽过氧化物酶活性降低以及促进炎症反应。研究表明,HHcy在体外和体内均可对内皮细胞造成直接损伤。临床上,这表现为血流介导的血管舒张功能受损,主要原因是一氧化氮合成和生物利用度降低。一氧化氮释放受损的影响反过来又可引发并加剧动脉粥样硬化血栓形成和氧化应激。内皮损伤是动脉粥样硬化的一个关键方面,且先于疾病的明显表现。此外,内皮功能障碍还与高血压、糖尿病、缺血再灌注损伤和神经退行性疾病有关。同型半胱氨酸是硫化氢(H2S)的前体,H2S由胱硫醚β-合酶和胱硫醚γ-裂解酶催化的转硫过程形成。H2S是一种气体信号分子,最近已成为心血管稳态中的一种新型介质。作为一种强效血管舒张剂,它发挥多种作用,包括调节血管直径、保护内皮免受氧化还原应激、缺血再灌注损伤和慢性炎症。然而,其介导这些有益作用的确切机制很复杂,仍不清楚。目前的证据表明,H2S通过多种细胞内信号转导过程调节细胞功能。在这篇综述中,我们总结了HHcy诱导内皮功能障碍的机制以及H2S作为一种保护剂的代谢和生理功能。